Improved diagnostics and change of tumour characteristics in breast cancer: a retrospective study over two decades

References

• Altobelli E, Lattanzi A. Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol. 2014;45:1785–1792.
   PubMed Web of Science ®Google Scholar
• Hakama M, Pukkala E, Heikkila M, et al. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. Br Med J. 1997;314:864–867.
   PubMed Web of Science ®Google Scholar
• Finnish Cancer Registry. [cited 2018 Feb]. Available from: https://www.Cancer.fi/syoparekisteri/
   Google Scholar
• Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.
   PubMed Web of Science ®Google Scholar
• Lousdal ML, Kristiansen IS, Moller B, et al. Effect of organised mammography screening on stage-specific incidence in Norway: population study. Br J Cancer. 2016;114:590–596.
   PubMed Web of Science ®Google Scholar
• Levi F, Bosetti C, Lucchini F, et al. Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev. 2005;14:497–502.
   PubMed Web of Science ®Google Scholar
• Carioli G, Malvezzi M, Rodriguez T, et al. Trends and predictions to 2020 in breast cancer mortality in Europe. Breast. 2017;36:89–95.
   PubMed Web of Science ®Google Scholar
• Ohuchi N, Suzuki A, Sobue T, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan strategic anti-cancer randomized trial (J-START): a randomised controlled trial. Lancet. 2016;387:341–348.
   PubMed Web of Science ®Google Scholar
• Nothacker M, Duda V, Hahn M, et al. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer. 2009;9:335–2407.
   PubMed Web of Science ®Google Scholar
• Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50:3–14.
   PubMed Web of Science ®Google Scholar
• Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155:493–502.
   PubMed Web of Science ®Google Scholar
• Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010;46:1296–1316.
   PubMed Web of Science ®Google Scholar
• Heikkinen S, Miettinen J, Koskenvuo M, et al. Proportion of women with self-reported opportunistic mammography before organized screening. Acta Oncol. 2016;55:865–869.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736–1747.
   PubMed Web of Science ®Google Scholar
• Crispo A, Barba M, D’Aiuto G, et al. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series. BMC Cancer. 2013;13:15.
   PubMed Web of Science ®Google Scholar
• Hofvind S, Holen A, Roman M, et al. Mode of detection: an independent prognostic factor for women with breast cancer. J Med Screen. 2016;23:89–97.
   PubMed Web of Science ®Google Scholar
• Redondo M, Funez R, Medina-Cano F, et al. Detection methods predict differences in biology and survival in breast cancer patients. BMC Cancer. 2012;12:604–2407.
   PubMed Web of Science ®Google Scholar
• Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144:1–10.
   PubMed Web of Science ®Google Scholar
• Collins JA, Blake JM, Crosignani PG. Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update. 2005;11:545–560.
   PubMed Web of Science ®Google Scholar
• Beral V. Million women study collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet. 2003;362:419–427.
   PubMed Web of Science ®Google Scholar
• Anderson WF, Katki HA, Rosenberg PS. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst. 2011;103:1397–1402.
   PubMedGoogle Scholar
• Anderson WF, Rosenberg PS, Petito L, et al. Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark. Int J Cancer. 2013;133:2201–2206.
   PubMed Web of Science ®Google Scholar
• Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18:457–471.
   PubMed Web of Science ®Google Scholar
• Lope V, Martin M, Castello A, et al. Physical Activity and breast cancer risk by pathological subtype. Gynecol Oncol. 2017;144:577–585.
   PubMed Web of Science ®Google Scholar
• Li CI, Chlebowski RT, Freiberg M, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study. J Natl Cancer Inst. 2010;102:1422–1431.
   PubMed Web of Science ®Google Scholar
• Crespi E, Bottai G, Santarpia L. Role of inflammation in obesity-related breast cancer. Curr Opin Pharmacol. 2016;31:114–122.
   PubMed Web of Science ®Google Scholar
• Reggiani F, Bertolini F. Roles of obesity in the development and progression of breast cancer. Discov Med. 2017;24:183–190.
   PubMed Web of Science ®Google Scholar
• Ravdin PM. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer. Breast Dis. 2008;30:3–8.
   PubMedGoogle Scholar
• Dossus L, Benusiglio PR. Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res. 2015;17:37.
   PubMed Web of Science ®Google Scholar
• Berube S, Provencher L, Robert J, et al. Quantitative exploration of possible reasons for the recent improvement in breast cancer survival. Breast Cancer Res Treat. 2007;106:419–431.
   PubMed Web of Science ®Google Scholar
• Jensen MB, Ejlertsen B, Mouridsen HT, et al. Improvements in breast cancer survival between 1995 and 2012 in Denmark: the importance of earlier diagnosis and adjuvant treatment. Acta Oncol. 2016;55:24–35.
   PubMed Web of Science ®Google Scholar
• Sala M, Domingo L, Macia F, et al. Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization. Eur Radiol. 2015;25:850–859.
   PubMed Web of Science ®Google Scholar
• Pathmanathan N, Provan PJ, Mahajan H, et al. Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. Breast. 2012;21:724–729.
   PubMed Web of Science ®Google Scholar
• Zhao J, Wu R, Au A, et al. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Mod Pathol. 2002;15:657–665.
   PubMed Web of Science ®Google Scholar